These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7741727)

  • 61. [Preventive effect of bombesin on alloxan-induced diabetes in rat].
    Song Y; Yu JR
    Sheng Li Xue Bao; 1991 Oct; 43(5):428-35. PubMed ID: 1796306
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
    Bolaffi JL; Rodd GG; Wang J; Grodsky GM
    Endocrinology; 1994 Feb; 134(2):537-42. PubMed ID: 7507826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan.
    Tyrberg B; Andersson A; Borg LA
    Gen Comp Endocrinol; 2001 Jun; 122(3):238-51. PubMed ID: 11356036
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 'Classical' and 'new' diabetogens--comparison of their effects on isolated rat pancreatic islets in vitro.
    Peschke E; Ebelt H; Brömme HJ; Peschke D
    Cell Mol Life Sci; 2000 Jan; 57(1):158-64. PubMed ID: 10949587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential insulin secretory activity in rat pancreatic islets and HIT cells.
    Tanigawa K; Kashiwada J; Tamura K; Kawaguchi M; Seino Y; Kato Y
    Diabetes Res; 1994; 26(1):1-11. PubMed ID: 7664532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Free radical modulation of insulin release in INS-1 cells exposed to alloxan.
    Janjic D; Maechler P; Sekine N; Bartley C; Annen AS; Wolheim CB
    Biochem Pharmacol; 1999 Mar; 57(6):639-48. PubMed ID: 10037448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alloxan uptake by isolated rat islets of Langerhans.
    Weaver DC; McDaniel ML; Lacy PE
    Endocrinology; 1978 Jun; 102(6):1847-55. PubMed ID: 369835
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential effect of alpha- and beta-D-glucose on protection against alloxan toxicity in isolated islets.
    Tomita T; Kobayashi M
    Biochem Biophys Res Commun; 1976 Dec; 73(3):791-8. PubMed ID: 795431
    [No Abstract]   [Full Text] [Related]  

  • 70. Characteristics of nicotinamide and N1-methylnicotinamide protection from alloxan diabetes in mice.
    Fischer LJ; Falany J; Fisher R
    Toxicol Appl Pharmacol; 1983 Aug; 70(1):148-55. PubMed ID: 6225223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Disappearance of glucose-induced oscillations of cytoplasmic Ca2+ in pancreatic beta-cells exposed to streptozotocin or alloxan.
    Grapengiesser E; Gylfe E; Hellman B
    Toxicology; 1990 Sep; 63(3):263-71. PubMed ID: 2145658
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activation of a novel non-selective cation channel by alloxan and H2O2 in the rat insulin-secreting cell line CRI-G1.
    Herson PS; Ashford ML
    J Physiol; 1997 May; 501 ( Pt 1)(Pt 1):59-66. PubMed ID: 9174994
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T
    Physiol Res; 2001; 50(6):537-46. PubMed ID: 11829314
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dimethylurea: a radical scavenger that protects isolated pancreatic islets from the effects of alloxan and dihydroxyfumarate exposure.
    Fischer LJ; Hamburger SA
    Life Sci; 1980 Apr; 26(17):1405-9. PubMed ID: 6991844
    [No Abstract]   [Full Text] [Related]  

  • 75. [Dynamics of insulin secretion in dogs with alloxan diabetes].
    Dagaeva LN; Belikova FS; Podotykina OI; Makarova AV
    Biull Eksp Biol Med; 1978 Mar; 85(3):278-81. PubMed ID: 352428
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanisms of diabetes mellitus induced with FK506 in SD rats models.
    Li QY; Li F; Sun JH; Chi YY; Yin HS; Liu SQ; Mei YH
    Immunopharmacol Immunotoxicol; 2009; 31(4):675-81. PubMed ID: 19874240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human islets in mixed islet grafts protect mouse pancreatic beta-cells from alloxan toxicity.
    Tyrberg B; Eizirik DL; Marklund SL; Olejnicka B; Madsen OD; Andersson A
    Pharmacol Toxicol; 1999 Dec; 85(6):269-75. PubMed ID: 10628902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Studies on the mechanism of alloxan inhibition of glucose-induced insulin release.
    Ishibashi F; Onari K; Sato T; Kawate R
    Hiroshima J Med Sci; 1978 Sep; 27(3):211-9. PubMed ID: 372145
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro.
    Devi MM; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2004 Nov; 71(5):309-18. PubMed ID: 15380818
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alloxan inhibits glucose oxidation in the pancreatic islets.
    Ishibashi F; Sato T; Onari K; Kawate R
    Endocrinol Jpn; 1979 Jun; 26(3):395-7. PubMed ID: 383474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.